The cold season is in full swing, throats are scratchy and noses are running. We feel ill and hope it is not the flu. The ...

Researchers from the University of Cologne and the Max Planck Institute of Biochemistry show that the targeted interaction of two proteins ensures that a key control mechanism in the formation of ...

Experts propose priorities to accelerate rare disease research, drug development, and patient access. Discover the key ...

Seasoned biotechnology commercial leader will drive global growth strategy Commercial team further bolstered by promotions of James Vang and ...

AIM-listed specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has promoted ...

Researchers have deciphered the process by which the influenza virus steals the cap of the host RNA to replicate.

According to Li-Qun Gu, DNA is an extremely compact, stable package of information. Natural DNA strands encode the biological blueprints of all life on Earth but ...

Christine Wolosin to chief commercial officer on Tuesday, as the AIM-traded synthetic DNA specialist accelerated its global growth strategy.

Some genetic mutations that are expected to completely stop a gene from working surprisingly cause only mild or even no symptoms. Researchers in ...

CAMBRIDGE, UK, 3 March 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the promotion of Christine Wolosin to ...

Ongoing research aims to confirm the mechanism by which ICP4 fluidizes the nucleus, which could indicate specific targets to counter viral replication.

UK-based 4basebio, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, says it has promoted Christine Wolosin to chief commercial officer.